• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:元延芳.新质生产力助力药品监管高质量发展的路径研究[J].药学研究,2025,44(2):145-149[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2667次   下载 1573次 本文二维码信息
码上扫一扫!
新质生产力助力药品监管高质量发展的路径研究
元延芳
字体:加大+|默认|缩小-
(国家药品监督管理局高级研修学院,北京 100073)
摘要:
习近平总书记关于新质生产力的一系列重要论述、重大部署,为药品监管高质量发展提供了基本遵循。本文主要探讨我国药品监管新质生产力的发展路径。当前我国药品创新在部分赛道已经实现跟跑向并跑转变,医药产业结构更新加快,药品监管对象的新质生产力特点正逐渐展现。推动药品监管新质生产力的主要因素在于劳动者和劳动工具即监管人员和监管工具。存在的问题包括:高素质药品监管人才缺口大,传统药品监管工具难以满足需求,尚未完全建立药品智慧监管模式等。据此,提出培养新时代药品监管科学创新人才,加快药品监管工具创新,推动药品监管模式创新等具体措施建议,以期加快发展药品监管新质生产力,助力药品监管高质量发展。
关键词:  新质生产力  药品监管  创新
DOI:10.13506/j.cnki.jpr.2025.02.008
基金项目:国家药品监督管理局药品监管科学体系建设重点项目(No.RS2024G002)
出版日期:2025-02-25
Study on the path of new quality productivity to promote high quality development of pharmaceutical regulation
YUAN Yanfang
(National Medical Products Administration Institute of Executive Development,Beijing 100073, China)
Abstract:
General Secretary Xi Jinping's series of important expositions and major deployments on new quality productivity have provided a basic guideline for the high-quality development of Drug regulation. This paper focuses on the development path of new quality productivity in China's drug regulation. At present, China's drug innovation in some tracks has realized the change from running behind to running in parallel, and the renewal of the structure of the pharmaceutical industry has accelerated, hence the characteristics of the new quality productivity of the drug regulatory object are gradually unfolding. The main factors driving the new quality productivity of drug regulation are laborers and labor tools, and that means the regulatory personnel and regulatory tools. Existing problems include a large shortage of high-quality regulatory personnel; traditional regulatory tools are difficult to meet the demand; and a smart regulatory model has not yet been fully established. Accordingly, specific measures are proposed to cultivate innovative talents in regulatory science in the new era, accelerate the innovation of drug regulatory tools and promote the innovation of drug regulatory models, with a view to accelerating the development of new quality productivity in drug regulation and contributing to the high-quality development of drug regulation.
Key words:  New quality productivity  Drug regulation  Innovation
今日访问量:2487    总访问量:55338927
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司